[1]
2020. ASSESSING LONG-TERM SERUM SAMPLE VIABILITY FOR CARDIOVASCULAR RISK PREDICTION IN RHEUMATOID ARTHRITIS. International Journal of Information Technology and Computer Engineering. 8, 2 (May 2020), 60–74.